Real-time fluorescent multiple cross displacement amplification for rapid and sensitive Mycoplasma pneumoniae detection

Front Cell Infect Microbiol. 2024 Aug 8:14:1423155. doi: 10.3389/fcimb.2024.1423155. eCollection 2024.

Abstract

Mycoplasma pneumoniae is a significant pathogen responsible for community-acquired pneumonia, predominantly affecting children and adolescents. Here, we devised a rapid method for M. pneumoniae that combined multiple cross displacement amplification (MCDA) with real-time fluorescence technology. A set of ten primers, which were specifically designed for M. pneumoniae detection, were employed in a real-time fluorescence MCDA reaction. Of these, one primer incorporated a restriction endonuclease recognition sequence, a fluorophore, and a quencher, facilitating real-time fluorescence detection. The real-time (RT)-MCDA reactions were monitored in a simple real-time fluorescence instrument and conducted under optimised conditions (64°C for 40 min). The detection limit of the M. pneumoniae RT-MCDA assay for genomic DNA extracted from M. pneumoniae culture was down to 43 fg/µl. This assay accurately identified M. pneumoniae strains without cross-reacting with other bacteria. To validate its practical application, we tested the M. pneumoniae RT-MCDA assay using genomic DNA extracted from clinical samples. The assay's detection capability proved comparable with real-time PCR, MCDA-based biosensor detection, and visual inspection under blue light. The entire process, including rapid DNA extraction and real-time MCDA detection, was completed within 1 h. Overall, the M. pneumoniae RT-MCDA assay reported here is a simple and effective diagnostic tool for rapid M. pneumoniae detection, which holds significant potential for point-of-care testing and in resource-limited regions.

Keywords: Mycoplasma pneumoniae; multiple cross displacement amplification; rapid diagnosis; real-time detection; restriction endonuclease.

MeSH terms

  • DNA Primers / genetics
  • DNA, Bacterial* / genetics
  • Fluorescence
  • Humans
  • Limit of Detection
  • Molecular Diagnostic Techniques / methods
  • Mycoplasma pneumoniae* / genetics
  • Mycoplasma pneumoniae* / isolation & purification
  • Nucleic Acid Amplification Techniques* / methods
  • Pneumonia, Mycoplasma* / diagnosis
  • Pneumonia, Mycoplasma* / microbiology
  • Real-Time Polymerase Chain Reaction / methods
  • Sensitivity and Specificity*

Substances

  • DNA, Bacterial
  • DNA Primers

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was funded by Beijing Nova Program (Grant No. Z211100002121042), National Natural Science Foundation of China (82200115), National Key Research and Development Program of China (Grant No. 2021YFC2301101 and 2021YFC2301102), Special Innovation and Promotion Project of Beijing Medical Administration (Grant No. XTCX201820) and the Research Foundation of Capital Institute of Pediatrics (Grant No. PX2021050).